Quick Answer
Revolution Medicines, Inc. reported Net Income of -$1.13 billion for fiscal year 2025.
Revolution Medicines, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$1.13B | -88.5% |
| 2024 | -$600.09M | -37.5% |
| 2023 | -$436.37M | -75.5% |
| 2022 | -$248.71M | -32.9% |
| 2021 | -$187.09M | -73.0% |
| 2020 | -$108.16M | -126.9% |
| 2019 | -$47.66M | -14.1% |
| 2018 | -$41.79M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$305.21M | -95.3% | -23.2% |
| June 30, 2025 | -$247.79M | -86.0% | -16.1% |
| March 31, 2025 | -$213.42M | -84.0% | -36.6% |
| September 30, 2024 | -$156.29M | -44.1% | -17.3% |
| June 30, 2024 | -$133.23M | -35.5% | -14.9% |
| March 31, 2024 | -$116.00M | -70.3% | -7.0% |
| September 30, 2023 | -$108.43M | -47.9% | -10.3% |
| June 30, 2023 | -$98.30M | -60.6% | -44.3% |
- Revolution Medicines, Inc. showed a decrease of -88.5% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Revolution Medicines, Inc.’s net income has declined by 2607.2% (from -$41.79 million to -$1.13 billion).
- The most recent figure is from Revolution Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: